Freedom Meditech’s ClearPath DS-120 Lens Fluorescence Biomicroscope is a tool designed to evaluate the crystalline lens of the human eye to detect chronic disease.

Freedom Meditech’s ClearPath DS-120 Lens Fluorescence Biomicroscope is a tool designed to evaluate the crystalline lens of the human eye to detect chronic disease.

FREEDOM MEDITECH

CEO: Craig Misrach.

Revenue: Pre-revenue.

No. of local employees: Three full-time employees, plus 42 active consultants. Two full-time employees and 20 active consultants are local.

Investors: 40 unnamed investors.

Headquarters: Corporate offices in San Diego with supporting engineering, ancillary research and development activities in Cleveland, Ohio.

Year founded: 2006.

Company description: Medical device developer.

Key factors for success: Regulatory clearance and being well-capitalized.

Freedom Meditech is taking some of the blood work out of diagnosing diabetes by developing a noninvasive method of detecting the chronic disease through an eye scan...